IART
Integra LifeSciences Holdings Corporation Healthcare - Medical Devices Investor Relations →
Integra LifeSciences Holdings Corporation (IART) closed at $17.58 as of 2026-06-19, trading 41.4% below its 200-week moving average of $29.99. This places IART in the extreme value zone. The stock is currently moving closer to the line, down from -41.1% last week. With a 14-week RSI of 90, IART is in overbought territory.
Trading volume is running at 1.4x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.96 ratio) is neutral — neither side is clearly dominating.
Over the past 1561 weeks of data, IART has crossed below its 200-week moving average 12 times. On average, these episodes lasted 49 weeks. Historically, investors who bought IART at the start of these episodes saw an average one-year return of +34.0%.
With a market cap of $1368 million, IART is a small-cap stock. The company generates a free cash flow yield of 5.1%, which is healthy. Return on equity stands at -38.6%. The stock trades at 1.3x book value.
The company has been aggressively buying back shares, reducing its share count by 6.9% over the past three years. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.
Over the past 30 years, a hypothetical investment of $100 in IART would have grown to $389, compared to $1953 for the S&P 500. IART has returned 4.6% annualized vs 10.4% for the index, underperforming the broader market over this period.
Free cash flow has been declining at a -100% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: IART vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After IART Crosses Below the Line?
Across 12 historical episodes, buying IART when it crossed below its 200-week moving average produced an average return of +35.4% after 12 months (median +24.0%), compared to +25.8% for the S&P 500 over the same periods. 75% of those episodes were profitable after one year. After 24 months, the average return was +36.2% vs +39.6% for the index.
Each line shows $100 invested at the moment IART crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. IART currently has negative free cash flow, so price-based dislocation levels are not available. The score still tracks yield deviation from baseline.
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from IART's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
IART has crossed below its 200-week MA 12 times with an average 1-year return of +34.0% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jul 1996 | Feb 2000 | 185 | 71.6% | -48.4% | +150.9% |
| May 2000 | May 2000 | 1 | 7.4% | +141.7% | +450.6% |
| Oct 2002 | Nov 2002 | 3 | 4.4% | +113.8% | +175.8% |
| Oct 2008 | Feb 2010 | 71 | 49.4% | -0.7% | +18.6% |
| May 2010 | Sep 2010 | 17 | 12.6% | +24.0% | +1.5% |
| Aug 2011 | Jul 2012 | 47 | 35.9% | +6.8% | +6.2% |
| Oct 2012 | Oct 2012 | 1 | 0.0% | +17.4% | +5.1% |
| Nov 2012 | Nov 2012 | 1 | 1.3% | +23.1% | +6.2% |
| Apr 2013 | Aug 2013 | 19 | 15.8% | +18.5% | +1.8% |
| Mar 2020 | May 2020 | 12 | 26.8% | +32.6% | -64.8% |
| Jun 2020 | Nov 2020 | 22 | 17.5% | +45.6% | -63.6% |
| Jun 2022 | Ongoing | 210+ | 73.5% | Ongoing | -67.7% |
| Average | 49 | — | +34.0% | — |
Frequently Asked Questions
Is IART below its 200-week moving average?
Yes. As of 2026-06-19, Integra LifeSciences Holdings Corporation (IART) is trading 41.4% below its 200-week moving average of $29.99. The current price is $17.58.
What is IART's 200-week moving average price?
Integra LifeSciences Holdings Corporation's 200-week moving average is $29.99 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when IART drops below its 200-week moving average?
IART has crossed below its 200-week moving average 12 times in our data. On average, buying at that moment produced a one-year return of +34.0%. These dips have historically been decent entry points. These episodes lasted 49 weeks on average.
Is IART a good value right now?
Here's what our data says about IART as of 2026-06-19: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 90 (overbought). Free cash flow yield is 5.1%. Return on equity is -38.6%. Price-to-book is 1.3x. This is not a buy or sell recommendation — always do your own research.
How does IART compare to the S&P 500?
Over the past 30 years, $100 invested in IART would have grown to $389, compared to $1953 for the S&P 500. That's 4.6% annualized vs 10.4% for the index. IART has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-06-19